Authors: Slain, D Rogers, PD Cleary, JD Chapman, SW

Citation: D. Slain et al., Intravenous itraconazole, ANN PHARMAC, 35(6), 2001, pp. 720-729

Authors: Slain, D

Citation: D. Slain, Intermittent antimycobacterial dosage correction, CLIN INF D, 32(2), 2001, pp. 321B-321B

Authors: Sadler, BM Chittick, GE Polk, RE Slain, D Kerkering, TM Studenberg, SD Lou, Y Moore, KHP Woolley, JL Stein, DS

Citation: Bm. Sadler et al., Metabolic disposition and pharmacokinetics of [C-14]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects, J CLIN PHAR, 41(4), 2001, pp. 386-396

Authors: Slain, D Pakyz, A Israel, DS Monroe, S Polk, RE

Citation: D. Slain et al., Variability in activity of hepatic CYP3A4 in patients infected with HIV, PHARMACOTHE, 20(8), 2000, pp. 900-909

Authors: Slain, D

Citation: D. Slain, Lipid-based amphotericin B for the treatment of fungal infections, PHARMACOTHE, 19(3), 1999, pp. 306-323